img

Global Radiation Emergency Medications Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Radiation Emergency Medications Market Insights, Forecast to 2034

Radiation emergency medications are pharmaceuticals used to treat individuals exposed to ionizing radiation during radiological or nuclear emergencies. Exposure to high levels of ionizing radiation can occur in incidents such as nuclear accidents, radiological attacks, or industrial accidents involving radioactive materials. Radiation can cause severe damage to cells and tissues, leading to acute radiation syndrome (ARS) or radiation sickness.
These medications aim to protect cells and tissues from the harmful effects of radiation. They can help minimize radiation-induced damage by scavenging free radicals and reducing oxidative stress. They can help reduce the severity of symptoms and improve outcomes for individuals exposed to radiation.
Global Radiation Emergency Medications market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Radiation Emergency Medications industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Radiation Emergency Medications key manufacturers include Amgen, Anbex, BTG International, Cellphire, Chrysalis BioTherapeutics, Darnitsa, Enzychem Lifesciences, Humanetics and Mission Pharmacal, etc. Amgen, Anbex, BTG International are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Radiation Emergency Medications were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Radiation Emergency Medications market and estimated to attract more attentions from industry insiders and investors.
Radiation Emergency Medications can be divided into Potassium lodide (KI), Prussian Blue, DTPA (Diethylenetriamine Pentaacetate) and Others, etc. Potassium lodide (KI) is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Radiation Emergency Medications is widely used in various fields, such as Acute Radiation Syndrome(ARS), Cancer Treatment, Radiation Exposure and Others, etc. Acute Radiation Syndrome(ARS) provides greatest supports to the Radiation Emergency Medications industry development. In 2022, global % sales of Radiation Emergency Medications went into Acute Radiation Syndrome(ARS) filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Radiation Emergency Medications market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Radiation Emergency Medications market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Amgen
Anbex
BTG International
Cellphire
Chrysalis BioTherapeutics
Darnitsa
Enzychem Lifesciences
Humanetics
Mission Pharmacal
Partner Therapeutics
Myelo Therapeutics
Pluri
Segment by Type
Potassium lodide (KI)
Prussian Blue
DTPA (Diethylenetriamine Pentaacetate)
Others

Segment by Application


Acute Radiation Syndrome(ARS)
Cancer Treatment
Radiation Exposure
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Radiation Emergency Medications plant distribution, commercial date of Radiation Emergency Medications, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Radiation Emergency Medications introduction, etc. Radiation Emergency Medications Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Radiation Emergency Medications
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Radiation Emergency Medications Product Introduction
1.2 Market by Type
1.2.1 Global Radiation Emergency Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Potassium lodide (KI)
1.2.3 Prussian Blue
1.2.4 DTPA (Diethylenetriamine Pentaacetate)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Radiation Emergency Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Acute Radiation Syndrome(ARS)
1.3.3 Cancer Treatment
1.3.4 Radiation Exposure
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Radiation Emergency Medications Sales Estimates and Forecasts 2018-2029
2.2 Global Radiation Emergency Medications Revenue by Region
2.2.1 Global Radiation Emergency Medications Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Radiation Emergency Medications Revenue by Region (2018-2024)
2.2.3 Global Radiation Emergency Medications Revenue by Region (2024-2029)
2.2.4 Global Radiation Emergency Medications Revenue Market Share by Region (2018-2029)
2.3 Global Radiation Emergency Medications Sales Estimates and Forecasts 2018-2029
2.4 Global Radiation Emergency Medications Sales by Region
2.4.1 Global Radiation Emergency Medications Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Radiation Emergency Medications Sales by Region (2018-2024)
2.4.3 Global Radiation Emergency Medications Sales by Region (2024-2029)
2.4.4 Global Radiation Emergency Medications Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Radiation Emergency Medications Sales by Manufacturers
3.1.1 Global Radiation Emergency Medications Sales by Manufacturers (2018-2024)
3.1.2 Global Radiation Emergency Medications Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Radiation Emergency Medications in 2022
3.2 Global Radiation Emergency Medications Revenue by Manufacturers
3.2.1 Global Radiation Emergency Medications Revenue by Manufacturers (2018-2024)
3.2.2 Global Radiation Emergency Medications Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Radiation Emergency Medications Revenue in 2022
3.3 Global Key Players of Radiation Emergency Medications, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Radiation Emergency Medications Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Radiation Emergency Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Radiation Emergency Medications, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Radiation Emergency Medications, Product Offered and Application
3.8 Global Key Manufacturers of Radiation Emergency Medications, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Radiation Emergency Medications Sales by Type
4.1.1 Global Radiation Emergency Medications Historical Sales by Type (2018-2024)
4.1.2 Global Radiation Emergency Medications Forecasted Sales by Type (2024-2029)
4.1.3 Global Radiation Emergency Medications Sales Market Share by Type (2018-2029)
4.2 Global Radiation Emergency Medications Revenue by Type
4.2.1 Global Radiation Emergency Medications Historical Revenue by Type (2018-2024)
4.2.2 Global Radiation Emergency Medications Forecasted Revenue by Type (2024-2029)
4.2.3 Global Radiation Emergency Medications Revenue Market Share by Type (2018-2029)
4.3 Global Radiation Emergency Medications Price by Type
4.3.1 Global Radiation Emergency Medications Price by Type (2018-2024)
4.3.2 Global Radiation Emergency Medications Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Radiation Emergency Medications Sales by Application
5.1.1 Global Radiation Emergency Medications Historical Sales by Application (2018-2024)
5.1.2 Global Radiation Emergency Medications Forecasted Sales by Application (2024-2029)
5.1.3 Global Radiation Emergency Medications Sales Market Share by Application (2018-2029)
5.2 Global Radiation Emergency Medications Revenue by Application
5.2.1 Global Radiation Emergency Medications Historical Revenue by Application (2018-2024)
5.2.2 Global Radiation Emergency Medications Forecasted Revenue by Application (2024-2029)
5.2.3 Global Radiation Emergency Medications Revenue Market Share by Application (2018-2029)
5.3 Global Radiation Emergency Medications Price by Application
5.3.1 Global Radiation Emergency Medications Price by Application (2018-2024)
5.3.2 Global Radiation Emergency Medications Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Radiation Emergency Medications Market Size by Type
6.1.1 US & Canada Radiation Emergency Medications Sales by Type (2018-2029)
6.1.2 US & Canada Radiation Emergency Medications Revenue by Type (2018-2029)
6.2 US & Canada Radiation Emergency Medications Market Size by Application
6.2.1 US & Canada Radiation Emergency Medications Sales by Application (2018-2029)
6.2.2 US & Canada Radiation Emergency Medications Revenue by Application (2018-2029)
6.3 US & Canada Radiation Emergency Medications Market Size by Country
6.3.1 US & Canada Radiation Emergency Medications Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Radiation Emergency Medications Sales by Country (2018-2029)
6.3.3 US & Canada Radiation Emergency Medications Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Radiation Emergency Medications Market Size by Type
7.1.1 Europe Radiation Emergency Medications Sales by Type (2018-2029)
7.1.2 Europe Radiation Emergency Medications Revenue by Type (2018-2029)
7.2 Europe Radiation Emergency Medications Market Size by Application
7.2.1 Europe Radiation Emergency Medications Sales by Application (2018-2029)
7.2.2 Europe Radiation Emergency Medications Revenue by Application (2018-2029)
7.3 Europe Radiation Emergency Medications Market Size by Country
7.3.1 Europe Radiation Emergency Medications Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Radiation Emergency Medications Sales by Country (2018-2029)
7.3.3 Europe Radiation Emergency Medications Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Radiation Emergency Medications Market Size
8.1.1 China Radiation Emergency Medications Sales (2018-2029)
8.1.2 China Radiation Emergency Medications Revenue (2018-2029)
8.2 China Radiation Emergency Medications Market Size by Application
8.2.1 China Radiation Emergency Medications Sales by Application (2018-2029)
8.2.2 China Radiation Emergency Medications Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Radiation Emergency Medications Market Size by Type
9.1.1 Asia Radiation Emergency Medications Sales by Type (2018-2029)
9.1.2 Asia Radiation Emergency Medications Revenue by Type (2018-2029)
9.2 Asia Radiation Emergency Medications Market Size by Application
9.2.1 Asia Radiation Emergency Medications Sales by Application (2018-2029)
9.2.2 Asia Radiation Emergency Medications Revenue by Application (2018-2029)
9.3 Asia Radiation Emergency Medications Sales by Region
9.3.1 Asia Radiation Emergency Medications Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Radiation Emergency Medications Revenue by Region (2018-2029)
9.3.3 Asia Radiation Emergency Medications Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Radiation Emergency Medications Market Size by Type
10.1.1 Middle East, Africa and Latin America Radiation Emergency Medications Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Radiation Emergency Medications Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Radiation Emergency Medications Market Size by Application
10.2.1 Middle East, Africa and Latin America Radiation Emergency Medications Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Radiation Emergency Medications Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Radiation Emergency Medications Sales by Country
10.3.1 Middle East, Africa and Latin America Radiation Emergency Medications Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Radiation Emergency Medications Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Radiation Emergency Medications Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Overview
11.1.3 Amgen Radiation Emergency Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Amgen Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen Recent Developments
11.2 Anbex
11.2.1 Anbex Company Information
11.2.2 Anbex Overview
11.2.3 Anbex Radiation Emergency Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Anbex Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Anbex Recent Developments
11.3 BTG International
11.3.1 BTG International Company Information
11.3.2 BTG International Overview
11.3.3 BTG International Radiation Emergency Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 BTG International Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BTG International Recent Developments
11.4 Cellphire
11.4.1 Cellphire Company Information
11.4.2 Cellphire Overview
11.4.3 Cellphire Radiation Emergency Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Cellphire Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cellphire Recent Developments
11.5 Chrysalis BioTherapeutics
11.5.1 Chrysalis BioTherapeutics Company Information
11.5.2 Chrysalis BioTherapeutics Overview
11.5.3 Chrysalis BioTherapeutics Radiation Emergency Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Chrysalis BioTherapeutics Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chrysalis BioTherapeutics Recent Developments
11.6 Darnitsa
11.6.1 Darnitsa Company Information
11.6.2 Darnitsa Overview
11.6.3 Darnitsa Radiation Emergency Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Darnitsa Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Darnitsa Recent Developments
11.7 Enzychem Lifesciences
11.7.1 Enzychem Lifesciences Company Information
11.7.2 Enzychem Lifesciences Overview
11.7.3 Enzychem Lifesciences Radiation Emergency Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Enzychem Lifesciences Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Enzychem Lifesciences Recent Developments
11.8 Humanetics
11.8.1 Humanetics Company Information
11.8.2 Humanetics Overview
11.8.3 Humanetics Radiation Emergency Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Humanetics Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Humanetics Recent Developments
11.9 Mission Pharmacal
11.9.1 Mission Pharmacal Company Information
11.9.2 Mission Pharmacal Overview
11.9.3 Mission Pharmacal Radiation Emergency Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Mission Pharmacal Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Mission Pharmacal Recent Developments
11.10 Partner Therapeutics
11.10.1 Partner Therapeutics Company Information
11.10.2 Partner Therapeutics Overview
11.10.3 Partner Therapeutics Radiation Emergency Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Partner Therapeutics Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Partner Therapeutics Recent Developments
11.11 Myelo Therapeutics
11.11.1 Myelo Therapeutics Company Information
11.11.2 Myelo Therapeutics Overview
11.11.3 Myelo Therapeutics Radiation Emergency Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Myelo Therapeutics Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Myelo Therapeutics Recent Developments
11.12 Pluri
11.12.1 Pluri Company Information
11.12.2 Pluri Overview
11.12.3 Pluri Radiation Emergency Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Pluri Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Pluri Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Radiation Emergency Medications Industry Chain Analysis
12.2 Radiation Emergency Medications Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Radiation Emergency Medications Production Mode & Process
12.4 Radiation Emergency Medications Sales and Marketing
12.4.1 Radiation Emergency Medications Sales Channels
12.4.2 Radiation Emergency Medications Distributors
12.5 Radiation Emergency Medications Customers
13 Market Dynamics
13.1 Radiation Emergency Medications Industry Trends
13.2 Radiation Emergency Medications Market Drivers
13.3 Radiation Emergency Medications Market Challenges
13.4 Radiation Emergency Medications Market Restraints
14 Key Findings in The Global Radiation Emergency Medications Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Radiation Emergency Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Potassium lodide (KI)
Table 3. Major Manufacturers of Prussian Blue
Table 4. Major Manufacturers of DTPA (Diethylenetriamine Pentaacetate)
Table 5. Major Manufacturers of Others
Table 6. Global Radiation Emergency Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Radiation Emergency Medications Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Radiation Emergency Medications Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Radiation Emergency Medications Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Radiation Emergency Medications Revenue Market Share by Region (2018-2024)
Table 11. Global Radiation Emergency Medications Revenue Market Share by Region (2024-2029)
Table 12. Global Radiation Emergency Medications Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Radiation Emergency Medications Sales by Region (2018-2024) & (K Units)
Table 14. Global Radiation Emergency Medications Sales by Region (2024-2029) & (K Units)
Table 15. Global Radiation Emergency Medications Sales Market Share by Region (2018-2024)
Table 16. Global Radiation Emergency Medications Sales Market Share by Region (2024-2029)
Table 17. Global Radiation Emergency Medications Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Radiation Emergency Medications Sales Share by Manufacturers (2018-2024)
Table 19. Global Radiation Emergency Medications Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Radiation Emergency Medications Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Radiation Emergency Medications, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Radiation Emergency Medications Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Radiation Emergency Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Radiation Emergency Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiation Emergency Medications as of 2022)
Table 25. Global Key Manufacturers of Radiation Emergency Medications, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Radiation Emergency Medications, Product Offered and Application
Table 27. Global Key Manufacturers of Radiation Emergency Medications, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Radiation Emergency Medications Sales by Type (2018-2024) & (K Units)
Table 30. Global Radiation Emergency Medications Sales by Type (2024-2029) & (K Units)
Table 31. Global Radiation Emergency Medications Sales Share by Type (2018-2024)
Table 32. Global Radiation Emergency Medications Sales Share by Type (2024-2029)
Table 33. Global Radiation Emergency Medications Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Radiation Emergency Medications Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Radiation Emergency Medications Revenue Share by Type (2018-2024)
Table 36. Global Radiation Emergency Medications Revenue Share by Type (2024-2029)
Table 37. Radiation Emergency Medications Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Radiation Emergency Medications Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Radiation Emergency Medications Sales by Application (2018-2024) & (K Units)
Table 40. Global Radiation Emergency Medications Sales by Application (2024-2029) & (K Units)
Table 41. Global Radiation Emergency Medications Sales Share by Application (2018-2024)
Table 42. Global Radiation Emergency Medications Sales Share by Application (2024-2029)
Table 43. Global Radiation Emergency Medications Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Radiation Emergency Medications Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Radiation Emergency Medications Revenue Share by Application (2018-2024)
Table 46. Global Radiation Emergency Medications Revenue Share by Application (2024-2029)
Table 47. Radiation Emergency Medications Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Radiation Emergency Medications Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Radiation Emergency Medications Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Radiation Emergency Medications Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Radiation Emergency Medications Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Radiation Emergency Medications Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Radiation Emergency Medications Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Radiation Emergency Medications Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Radiation Emergency Medications Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Radiation Emergency Medications Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Radiation Emergency Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Radiation Emergency Medications Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Radiation Emergency Medications Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Radiation Emergency Medications Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Radiation Emergency Medications Sales by Country (2024-2029) & (K Units)
Table 62. Europe Radiation Emergency Medications Sales by Type (2018-2024) & (K Units)
Table 63. Europe Radiation Emergency Medications Sales by Type (2024-2029) & (K Units)
Table 64. Europe Radiation Emergency Medications Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Radiation Emergency Medications Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Radiation Emergency Medications Sales by Application (2018-2024) & (K Units)
Table 67. Europe Radiation Emergency Medications Sales by Application (2024-2029) & (K Units)
Table 68. Europe Radiation Emergency Medications Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Radiation Emergency Medications Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Radiation Emergency Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Radiation Emergency Medications Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Radiation Emergency Medications Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Radiation Emergency Medications Sales by Country (2018-2024) & (K Units)
Table 74. Europe Radiation Emergency Medications Sales by Country (2024-2029) & (K Units)
Table 75. China Radiation Emergency Medications Sales by Type (2018-2024) & (K Units)
Table 76. China Radiation Emergency Medications Sales by Type (2024-2029) & (K Units)
Table 77. China Radiation Emergency Medications Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Radiation Emergency Medications Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Radiation Emergency Medications Sales by Application (2018-2024) & (K Units)
Table 80. China Radiation Emergency Medications Sales by Application (2024-2029) & (K Units)
Table 81. China Radiation Emergency Medications Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Radiation Emergency Medications Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Radiation Emergency Medications Sales by Type (2018-2024) & (K Units)
Table 84. Asia Radiation Emergency Medications Sales by Type (2024-2029) & (K Units)
Table 85. Asia Radiation Emergency Medications Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Radiation Emergency Medications Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Radiation Emergency Medications Sales by Application (2018-2024) & (K Units)
Table 88. Asia Radiation Emergency Medications Sales by Application (2024-2029) & (K Units)
Table 89. Asia Radiation Emergency Medications Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Radiation Emergency Medications Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Radiation Emergency Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Radiation Emergency Medications Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Radiation Emergency Medications Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Radiation Emergency Medications Sales by Region (2018-2024) & (K Units)
Table 95. Asia Radiation Emergency Medications Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Radiation Emergency Medications Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Radiation Emergency Medications Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Radiation Emergency Medications Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Radiation Emergency Medications Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Radiation Emergency Medications Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Radiation Emergency Medications Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Radiation Emergency Medications Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Radiation Emergency Medications Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Radiation Emergency Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Radiation Emergency Medications Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Radiation Emergency Medications Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Radiation Emergency Medications Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Radiation Emergency Medications Sales by Country (2024-2029) & (K Units)
Table 109. Amgen Company Information
Table 110. Amgen Description and Major Businesses
Table 111. Amgen Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Amgen Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Amgen Recent Developments
Table 114. Anbex Company Information
Table 115. Anbex Description and Major Businesses
Table 116. Anbex Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Anbex Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Anbex Recent Developments
Table 119. BTG International Company Information
Table 120. BTG International Description and Major Businesses
Table 121. BTG International Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. BTG International Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. BTG International Recent Developments
Table 124. Cellphire Company Information
Table 125. Cellphire Description and Major Businesses
Table 126. Cellphire Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Cellphire Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Cellphire Recent Developments
Table 129. Chrysalis BioTherapeutics Company Information
Table 130. Chrysalis BioTherapeutics Description and Major Businesses
Table 131. Chrysalis BioTherapeutics Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Chrysalis BioTherapeutics Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Chrysalis BioTherapeutics Recent Developments
Table 134. Darnitsa Company Information
Table 135. Darnitsa Description and Major Businesses
Table 136. Darnitsa Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Darnitsa Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Darnitsa Recent Developments
Table 139. Enzychem Lifesciences Company Information
Table 140. Enzychem Lifesciences Description and Major Businesses
Table 141. Enzychem Lifesciences Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Enzychem Lifesciences Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Enzychem Lifesciences Recent Developments
Table 144. Humanetics Company Information
Table 145. Humanetics Description and Major Businesses
Table 146. Humanetics Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Humanetics Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Humanetics Recent Developments
Table 149. Mission Pharmacal Company Information
Table 150. Mission Pharmacal Description and Major Businesses
Table 151. Mission Pharmacal Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Mission Pharmacal Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Mission Pharmacal Recent Developments
Table 154. Partner Therapeutics Company Information
Table 155. Partner Therapeutics Description and Major Businesses
Table 156. Partner Therapeutics Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Partner Therapeutics Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Partner Therapeutics Recent Developments
Table 159. Myelo Therapeutics Company Information
Table 160. Myelo Therapeutics Description and Major Businesses
Table 161. Myelo Therapeutics Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Myelo Therapeutics Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Myelo Therapeutics Recent Developments
Table 164. Pluri Company Information
Table 165. Pluri Description and Major Businesses
Table 166. Pluri Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Pluri Radiation Emergency Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Pluri Recent Developments
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Radiation Emergency Medications Distributors List
Table 172. Radiation Emergency Medications Customers List
Table 173. Radiation Emergency Medications Market Trends
Table 174. Radiation Emergency Medications Market Drivers
Table 175. Radiation Emergency Medications Market Challenges
Table 176. Radiation Emergency Medications Market Restraints
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiation Emergency Medications Product Picture
Figure 2. Global Radiation Emergency Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Radiation Emergency Medications Market Share by Type in 2022 & 2029
Figure 4. Potassium lodide (KI) Product Picture
Figure 5. Prussian Blue Product Picture
Figure 6. DTPA (Diethylenetriamine Pentaacetate) Product Picture
Figure 7. Others Product Picture
Figure 8. Global Radiation Emergency Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Radiation Emergency Medications Market Share by Application in 2022 & 2029
Figure 10. Acute Radiation Syndrome(ARS)
Figure 11. Cancer Treatment
Figure 12. Radiation Exposure
Figure 13. Others
Figure 14. Radiation Emergency Medications Report Years Considered
Figure 15. Global Radiation Emergency Medications Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Radiation Emergency Medications Revenue 2018-2029 (US$ Million)
Figure 17. Global Radiation Emergency Medications Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Radiation Emergency Medications Revenue Market Share by Region (2018-2029)
Figure 19. Global Radiation Emergency Medications Sales 2018-2029 ((K Units)
Figure 20. Global Radiation Emergency Medications Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Radiation Emergency Medications Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Radiation Emergency Medications Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Radiation Emergency Medications Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Radiation Emergency Medications Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Radiation Emergency Medications Sales YoY (2018-2029) & (K Units)
Figure 26. China Radiation Emergency Medications Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Radiation Emergency Medications Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) Radiation Emergency Medications Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Radiation Emergency Medications Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America Radiation Emergency Medications Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Radiation Emergency Medications Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Radiation Emergency Medications in the World: Market Share by Radiation Emergency Medications Revenue in 2022
Figure 33. Global Radiation Emergency Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Radiation Emergency Medications Sales Market Share by Type (2018-2029)
Figure 35. Global Radiation Emergency Medications Revenue Market Share by Type (2018-2029)
Figure 36. Global Radiation Emergency Medications Sales Market Share by Application (2018-2029)
Figure 37. Global Radiation Emergency Medications Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Radiation Emergency Medications Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Radiation Emergency Medications Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Radiation Emergency Medications Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Radiation Emergency Medications Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Radiation Emergency Medications Revenue Share by Country (2018-2029)
Figure 43. US & Canada Radiation Emergency Medications Sales Share by Country (2018-2029)
Figure 44. U.S. Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Radiation Emergency Medications Sales Market Share by Type (2018-2029)
Figure 47. Europe Radiation Emergency Medications Revenue Market Share by Type (2018-2029)
Figure 48. Europe Radiation Emergency Medications Sales Market Share by Application (2018-2029)
Figure 49. Europe Radiation Emergency Medications Revenue Market Share by Application (2018-2029)
Figure 50. Europe Radiation Emergency Medications Revenue Share by Country (2018-2029)
Figure 51. Europe Radiation Emergency Medications Sales Share by Country (2018-2029)
Figure 52. Germany Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 53. France Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 57. China Radiation Emergency Medications Sales Market Share by Type (2018-2029)
Figure 58. China Radiation Emergency Medications Revenue Market Share by Type (2018-2029)
Figure 59. China Radiation Emergency Medications Sales Market Share by Application (2018-2029)
Figure 60. China Radiation Emergency Medications Revenue Market Share by Application (2018-2029)
Figure 61. Asia Radiation Emergency Medications Sales Market Share by Type (2018-2029)
Figure 62. Asia Radiation Emergency Medications Revenue Market Share by Type (2018-2029)
Figure 63. Asia Radiation Emergency Medications Sales Market Share by Application (2018-2029)
Figure 64. Asia Radiation Emergency Medications Revenue Market Share by Application (2018-2029)
Figure 65. Asia Radiation Emergency Medications Revenue Share by Region (2018-2029)
Figure 66. Asia Radiation Emergency Medications Sales Share by Region (2018-2029)
Figure 67. Japan Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 71. India Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Radiation Emergency Medications Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Radiation Emergency Medications Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Radiation Emergency Medications Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Radiation Emergency Medications Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Radiation Emergency Medications Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Radiation Emergency Medications Sales Share by Country (2018-2029)
Figure 78. Brazil Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Radiation Emergency Medications Revenue (2018-2029) & (US$ Million)
Figure 83. Radiation Emergency Medications Value Chain
Figure 84. Radiation Emergency Medications Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries